Bank Of America Corp Aligos Therapeutics, Inc. Transaction History

Bank Of America Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.35 - $1.07 $116,094 - $354,916	-331,698 Reduced 28.9%	816,029 $285,000
Q1 2024 May 15, 2024	SELL	$0.64 - $1.13 $22 - $39	-35 Reduced -0.0%	1,147,727 $1.12 Million
Q4 2023 Feb 14, 2024	SELL	$0.56 - $0.8 $1,782 - $2,546	-3,183 Reduced 0.28%	1,147,762 $757,000
Q2 2023 Aug 14, 2023	BUY	$0.89 - $1.36 $2,814 - $4,300	3,162 Added 0.28%	1,150,945 $1.12 Million
Q1 2023 May 12, 2023	SELL	$0.87 - $2.11 $2,057 - $4,990	-2,365 Reduced 0.21%	1,147,783 $998,000
Q4 2022 Feb 10, 2023	BUY	$0.89 - $28.0 $1,785 - $56,168	2,006 Added 0.17%	1,150,148 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.5 $10,993 - $285,202	10,371 Added 0.91%	1,148,142 $1.26 Million
Q2 2022 Aug 12, 2022	SELL	$1.04 - $2.14 $48,346 - $99,482	-46,487 Reduced 3.93%	1,137,771 $1.38 Million
Q1 2022 May 16, 2022	BUY	$2.08 - $12.2 $41,512 - $243,487	19,958 Added 1.71%	1,184,258 $2.55 Million
Q4 2021 Feb 08, 2022	BUY	$11.48 - $17.69 $13 Million - $20 Million	1,130,571 Added 3351.93%	1,164,300 $13.8 Million
Q3 2021 Nov 15, 2021	BUY	$14.57 - $17.72 $247,471 - $300,974	16,985 Added 101.44%	33,729 $522,000
Q2 2021 Sep 13, 2021	BUY	$20.3 - $33.6 $339,903 - $562,598	16,744 New	16,744 $341,000

253K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.